Medicinal Cannabis and CBD in Mental Healthcare

1. Auflage 2021
ISBN: 978-3-030-78558-1
Verlag: Springer

Buch, Englisch, 576 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 1114 g

This book functions as a clinician’s guide to the use of cannabidiol (CBD) in the treatment of mental health conditions. It conveys the scientific evidence of efficacy of CBD as well as THC and addresses the social stigma attached to its medical use.

The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC. Chapters on specific mental health conditions describe the underpinning pathomechanisms including how the endocannabinoid system is involved, and summarises the scientific evidence including animal and human research for the use of CBD and THC in treatment of such conditions. Topics covered include anxiety, depression, post-traumatic stress disorder, insomnia, Alzheimer's Disease and autism spectrum disorder. Chapters also discuss treatment guidelines and case studies.



Unique and focused, Medicinal Cannabis and CBD in Mental Healthcare is an invaluable reference for medical practitioners seeking to adopt CBD-use in their treatment plans.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

O'Brien, Kylie

Blair, Philip

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete AINS Schmerzmedizin & Schmerztherapie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Allgemeinmedizin, Familienmedizin
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Psychiatrie, Sozialpsychiatrie, Suchttherapie

Inhaltsverzeichnis

Introduction.- Endocannabinoid system.- ECS and regulation of stress.- Overview of cannabis.- Stress and Anxiety.-Depression.- PSTD.- Sleep.- Alzheimers.- Autism.- Conclusion.

Über Autor(innen)

Professor Kylie O’Brien PhD
Kylie O’Brien PhD

Adjunct Professor Torrens University

Director of Research & Education

International College of Cannabinoid Medicine
Email: [e-mail]

Phone: [phone]
Dr Philip Blair, MD
Dr. Philip Blair, MD, Colonel (US Army Ret)

CEO of AbleDoc, Inc, International Medical Consultant

Chief Medical Officer, International College of Cannabinoid Medicine

Chief Medical Officer, Releaf Clinics, Australia

Chief Science Officer for Harvest 360

Castle Rock, Washington
email: [e-mail]